Docket #: S21-137
Metabolic Subphenotype Predictor – software for continuous glucose monitoring
Stanford researchers at the Snyder Lab have developed a novel software application, called the Metabolic Subphenotype Predictor, which predicts if a patient is insulin resistant through continuous glucose monitoring.
Current methods of identifying pre-diabetes are blood tests that predict insulin resistance, but do not identify other metabolic subphenotypes. Additionally, these tests are not readily available to the general public. This method defines the dominant metabolic phenotype using the shape of a glucose curve after administering an oral glucose tolerance test. This invention makes testing for diabetes more accessible and cost effective, while providing personalized medical treatment and targeted lifestyle interventions.
Stage of Development
Research -
in vivo
Related Technology
Stanford Docket S18-198-Continuous glucose monitoring classification algorithm to identify glucotypes at diabetes risk
Applications
- Companion software for continuous glucose monitoring devices
Advantages
- Novel software application that is not available anywhere else
- Accessible diagnosis for rural and underserved areas
- Personalization of medical treatment and targeted lifestyle interventions based on the identification of the dominant metabolic phenotype
Related Links
Patents
- Published Application: 20220406400
Similar Technologies
-
Electrochemical Sensor Enables Long-term Analyte Detection In Complex Biological Samples S23-420Electrochemical Sensor Enables Long-term Analyte Detection In Complex Biological Samples
-
A System for Assessing Neuropsychiatric Brain States Using Neural and Behavioral Biomarkers S24-461A System for Assessing Neuropsychiatric Brain States Using Neural and Behavioral Biomarkers
-
DART-Met: Dynamic AI-Driven Raman Techniques for Biomarker monitoring in Metabolic disorders S25-113DART-Met: Dynamic AI-Driven Raman Techniques for Biomarker monitoring in Metabolic disorders